The Incidence and Management of Pulmonary Mycosis in Renal Allograft Patients
- 1 November 1975
- journal article
- research article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 182 (5) , 617-626
- https://doi.org/10.1097/00000658-197511000-00014
Abstract
A retrospective analysis of 193 renal transplant recipients yielded 15 patients who developed pulmonary mycosis post-transplantation and one case in which mycotic lung infection existed at the time of transplant surgery. Agents responsible for infection included Nocardia asteroides in 8 cases, Aspergillus flavus in 5 cases, Cryptococcus neoformans in 4 patients and Candida albicans in 2 cases. Two cases had mixed mycotic infections. Ten patients died, of which 7 had diagnosis established antemortem. Two cases had diagnosis established by thoracotomy and 1 case by transtracheal aspiration. Problems in establishing accurate diagnosis are discussed with emphasis placed on the need for more frequent use of transtracheal aspiration and thoracotomy for precise diagnosis.Keywords
This publication has 28 references indexed in Scilit:
- Systemic fungal infections complicating renal transplantation and immunosuppressive therapyThe American Journal of Medicine, 1967
- Infectious Pulmonary Disease in Patients Receiving Immunosuppressive Therapy for Organ TransplantationNew England Journal of Medicine, 1964
- Infectious Diseases Associated With Renal HomotransplantationJAMA, 1964
- Secondary AspergillosisAnnals of Internal Medicine, 1964
- The Improved Prognosis of Cryptococcal Meningitis with Amphotericin B TherapyAnnals of Internal Medicine, 1963
- OCCURRENCE OF OPPORTUNISTIC FUNGUS INFECTIONS IN A CANCER HOSPITAL1962
- Cryptococcal Infection Following Steroid TherapyAnnals of Internal Medicine, 1962
- ANALYSIS OF AMPHOTERICIN TREATMENT FAILURES IN SYSTEMIC FUNGAL DISEASEAnnals of the New York Academy of Sciences, 1960
- Fungus infections associated with antibiotic and steroid therapyThe American Journal of Medicine, 1957
- MONILIASIS PNEUMONIA FOLLOWING AUREOMYCIN THERAPYThe Lancet, 1952